2016-12-10T02-17-59Z
Source: Indo American Journal of Pharmaceutical Research
K. Sai Supraja, Ayemen Almeen, Mariya Kauser, Aiswarya Roy .P, Sarvan Kumar .G, Surender .N.
Chronic renal failure is a slow progressive loss of kidney function over a period of several years. The main role of the kidneys is to remove wastes and excess water from the body. Chronic kidney disease (CKD) slowly gets worse over months or years. The loss of function may be so slow that may not have symptoms until kidneys have almost stopped working. Chronic kidney disease is much more common than people realize, and often goes undetected and undiagnosed until the disease is well advanced and kidney failure is fairly imminent. As kidney failure advances and the organ's function is seriously impaired, dangerous levels of waste and fluid can rapidly build up in the body. Treatment is aimed at stopping or slowing down the progression of the disease - this is usually done by controlling its underlying cause.The final stage of CKD is called end stage renal disease (ESRD) and renal transplant. Eventually the patient has permanent kidney failure patients with chronic kidney disease have multiple co - morbidities and require complicated therapeutic regimen. Clinical pharmacists specifically manage lab tests, follow up, adapt drug dosage according to guidelines and evaluate cardiovascular risk factors and decline in renal function. The purpose of the study was to summarize the available evidence regarding the role and impact of clinical pharmacy services for these patient populations. The ultimate goal of intervention in patients with chronic kidney failure is to improve the quality of life of patients.
http://ift.tt/2hhVjjt
Σάββατο 10 Δεκεμβρίου 2016
CLINICAL PHARMACIST INTERVENTION IN THE MANAGEMENT OF PATIENTS WITH CHRONIC RENAL FAILURE
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Publication date: Available online 4 January 2018 Source: European Journal of Radiology Author(s): Peiyao Zhang, Jing Wang, Qin Xu, Zhen...
-
Publication date: March 2017 Source: Free Radical Biology and Medicine, Volume 104 from #AlexandrosSfakianakis via Alexandros G.Sfak...
-
Dtsch med Wochenschr DOI: 10.1055/s-0043-100054 Hintergrund und Fragestellung Ein etablierter Weg, die optimale Behandlung von Tumorpatien...
-
Does CBD Oil Lower Blood Pressure? This article was originally published at SundayScaries." Madeline Taylor POSTED ON January 13, 20...
-
Antibodies, Vol. 9, Pages 21: Construction of Ant... In Vivo and In Vitro Evaluation of Bull Semen Pro... Vertebral artery fenestration mimi...
-
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182, Butyric Acid from Probiotic Staphyloco...
-
Abstract Purpose F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) is emerging to be a useful tool in supporting the diag...
-
Publication date: December 2017 Source: Advances in Biological Regulation, Volume 66 Author(s): Lauren Rusnak, Haian Fu The mitogen-activ...
-
Correction to: The IL-23p19/EBI3 heterodimeric cytokine termed IL-39 remains a theoretical cytokine in man The original article can be found...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου